UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sanibel Captiva Trust Company Inc.

Sanibel Captiva Trust Company Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,744 shares of the healthcare conglomerate’s stock after selling 80 shares during the period. UnitedHealth Group accounts for about 1.2% of Sanibel Captiva Trust Company Inc.’s holdings, making the stock its 19th biggest holding. Sanibel Captiva Trust Company Inc.’s holdings in UnitedHealth Group were worth $39,024,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Visionary Wealth Advisors increased its stake in UnitedHealth Group by 3.2% during the fourth quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock worth $649,000 after acquiring an additional 38 shares during the last quarter. Garner Asset Management Corp purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $132,000. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $31,000. Waverly Advisors LLC grew its stake in shares of UnitedHealth Group by 90.8% in the fourth quarter. Waverly Advisors LLC now owns 9,710 shares of the healthcare conglomerate’s stock valued at $5,112,000 after buying an additional 4,622 shares in the last quarter. Finally, Pinnacle Holdings LLC boosted its holdings in UnitedHealth Group by 1.0% during the 4th quarter. Pinnacle Holdings LLC now owns 10,503 shares of the healthcare conglomerate’s stock valued at $5,530,000 after acquiring an additional 99 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 1st. Royal Bank of Canada lifted their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. TD Cowen lifted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Barclays upped their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $591.22 on Thursday. The company has a market cap of $545.94 billion, a PE ratio of 36.14, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a 50-day simple moving average of $582.68 and a 200-day simple moving average of $529.13.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period in the prior year, the firm posted $6.14 earnings per share. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.